Morten Fenger-Grøn

Morten Fenger-Grøn

Auto-generated profile, based on publicly available information

Morten Fenger-Grøn

Department of Occupational and Environmental Medicine, Danish Ramazzini Centre, Aarhus University Hospital, Denmark; Medical Diagnostic Center, University Research Clinic for Innovative Patient Pathways, Regional Hospital Central Jutland, Silkeborg, Denmark

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
NMNatalie C. Momen
Natalie C. Momen
OPOleguer Plana-Ripoll
Oleguer Plana-Ripoll
EAEsben Agerbo
Esben Agerbo
MBMichael Eriksen Benros
Michael Eriksen Benros
ABAnders D. Børglum
Anders D. Børglum
JMJohn McGrath
John McGrath
Persons with mental disorders are at a higher risk than the general population for the subsequent development of certain medical conditions.

1 May 2018 in The Lancet Psychiatry
Verified
Journal Article
Closed access
JFJesse R Fann
Jesse R Fann
ARAnette Riisgaard Ribe
Anette Riisgaard Ribe
HPHenrik Schou Pedersen
Henrik Schou Pedersen
MFMorten Fenger-Grøn
Morten Fenger-Grøn
JCJakob Christensen
Jakob Christensen
MVMogens Vestergaard
Mogens Vestergaard

15 August 2023 in BMC Medicine
Verified
Journal Article
Open access
PDF file
APAnders Prior
Anders Prior
CVClaus Høstrup Vestergaard
Claus Høstrup Vestergaard
PVPeter Vedsted
Peter Vedsted
SSSusan M. Smith
Susan M. Smith
LVLine Flytkjær Virgilsen
Line Flytkjær Virgilsen
MFMorten Fenger-Grøn
Morten Fenger-Grøn
Background: Patients with multimorbidity are frequent users of healthcare, but fragmented care may lead to suboptimal treatment. Yet, this has never been examined across healthcare sectors on a national scale. We aimed to quantify care fragmentation using various measures and to analyze the associations with patient outcomes. Methods: We conducted a register-based nationwide cohort study with 4.7 million Danish adult citizens. All healthcare contacts to primary care and hospitals during 2018 were recorded. Clinical fragmentation indicators included number of healthcare contacts, involved providers, provider transitions, and hospital trajectories. Formal fragmentation indices assessed care concentration, dispersion, and contact sequence. The patient outcomes were potentially inappropriate medication and all-cause mortality adjusted for demographics, socioeconomic factors, and morbidity level. Results: The number of involved healthcare providers, provider transitions, and hospital trajectories rose with increasing morbidity levels. Patients with 3 versus 6 conditions had a mean of 4.0 versus 6.9 involved providers and 6.6 versus 13.7 provider transitions. The proportion of contacts to the patient’s own general practice remained stable across morbidity levels. High levels of care fragmentation were associated with higher rates of potentially inappropriate medication and increased mortality on all fragmentation measures after adjusting for demographic characteristics, socioeconomic factors, and morbidity. The strongest associations with potentially inappropriate medication and mortality were found for ≥ 20 contacts versus none (incidence rate ratio 2.83, 95% CI 2.77–2.90) and ≥ 20 hospital trajectories versus none (hazard ratio 10.8, 95% CI 9.48–12.4), respectively. Having less than 25% of contacts with your usual provider was associated with an incidence rate ratio of potentially inappropriate medication of 1.49 (95% CI 1.40–1.58) and a mortality hazard ratio of 2.59 (95% CI 2.36–2.84) compared with full continuity. For the associations between fragmentation measures and patient outcomes, there were no clear interactions with number of conditions. Conclusions: Several clinical indicators of care fragmentation were associated with morbidity level. Care fragmentation was associated with higher rates of potentially inappropriate medication and increased mortality even when adjusting for the most important confounders. Frequent contact to the usual provider, fewer transitions, and better coordination were associated with better patient outcomes regardless of morbidity level.

11 July 2016 in American Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
APAnders Prior
Anders Prior
MFMorten Fenger-Grøn
Morten Fenger-Grøn
KLKaren Kjær Larsen
Karen Kjær Larsen
FLFinn Breinholt Larsen
Finn Breinholt Larsen
KRKirstine Magtengaard Robinson
Kirstine Magtengaard Robinson
MVMogens Vestergaard
Mogens Vestergaard
Multimorbidity is common and is associated with poor mental health and high mortality. Nevertheless, no studies have evaluated whether mental health may affect the survival of people with multimorbidity. We investigated the association between perceived stress and mortality in people with multimorbidity by following a population-based cohort of 118,410 participants from the Danish National Health Survey 2010 for up to 4 years. Information on perceived stress and lifestyle was obtained from the survey. We assessed multimorbidity using nationwide register data on 39 conditions and identified 4,229 deaths for the 453,648 person-years at risk. Mortality rates rose with increasing levels of stress in a dose-response relationship (P-trend < 0.0001), independently of multimorbidity status. Mortality hazard ratios (highest stress quintile vs. lowest) were 1.51 (95% confidence interval (CI): 1.25, 1.84) among persons without multimorbidity, 1.39 (95% CI: 1.18, 1.64) among those with 2 or 3 conditions, and 1.43 (95% CI: 1.18, 1.73) among those with 4 or more conditions, when adjusted for disease severities, lifestyle, and socioeconomic status. The numbers of excess deaths associated with high stress were 69 among persons without multimorbidity, 128 among those with 2 or 3 conditions, and 255 among those with 4 or more conditions. Our findings suggested that perceived stress contributes significantly to higher mortality rates in a dose-response pattern, and more stress-associated deaths occurred in people with multimorbidity.

1 June 2015 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
WKWayne Katon
Wayne Katon
HPHenrik Sondergaard Pedersen
Henrik Sondergaard Pedersen
ARAnette Riisgaard Ribe
Anette Riisgaard Ribe
MFMorten Fenger-Grøn
Morten Fenger-Grøn
DDDimitry Davydow
Dimitry Davydow
MVMogens Vestergaard
Mogens Vestergaard
Diabetes mellitus (DM) and major depression are very common in Western populations. Type 2 DM occurs in approximately 8% to 14% of most Western populations,1 whereas approximately 25% of women and 16% of men will have a major depressive episode during their lifetime.2 Quiz Ref ID As many as 20% of persons with type 2 DM have comorbid depression.3 Furthermore, a recent meta-analysis has established a bidirectional link between depression and DM.4 Patients with comorbid depression and DM have poorer adherence to diet, smoking cessation, exercise, and medication regimens to control DM.5 Depression is also associated with increased cortisol levels,6 autonomic nervous system dysregulation,7 and increased inflammation,8 all of which worsen glycemic control. Therefore, patients with comorbid depression and DM have an increased risk for microvascular and macrovascular complications and mortality.9

1 November 2015 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
ARAnette Riisgaard Ribe
Anette Riisgaard Ribe
TLThomas Munk Laursen
Thomas Munk Laursen
MCMorten Charles
Morten Charles
WKWayne Katon
Wayne Katon
MFMorten Fenger-Grøn
Morten Fenger-Grøn
MVMogens Vestergaard
Mogens Vestergaard
Dementia is one of the major challenges for modern health care1 and places a substantial financial burden on society.2 The disorder is a clinical syndrome characterized by cognitive decline and impairment in activities of daily living.1 In the Western world, dementia affects 5% to 6% of persons older than 60 years.3 The prevalence of dementia is expected to double every 20 years through 2040 owing to changes in population demographics and increased life expectancy.3